Kymera Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2020 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Kymera Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2020 to Q2 2024.
  • Kymera Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 2, 2024 was 61.8M shares, a 11.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 61.8M +6.34M +11.4% Aug 2, 2024 10-Q 2024-08-07
Q1 2024 61.4M +6.05M +10.9% Apr 26, 2024 10-Q 2024-05-02
Q3 2023 55.5M +623K +1.14% Oct 27, 2023 10-Q 2023-11-02
Q2 2023 55.4M +3.55M +6.84% Jul 28, 2023 10-Q 2023-08-03
Q1 2023 55.3M +3.58M +6.93% Apr 28, 2023 10-Q 2023-05-04
Q3 2022 54.9M +3.48M +6.77% Oct 28, 2022 10-Q 2022-11-03
Q2 2022 51.9M +823K +1.61% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 51.7M +6.69M +14.9% Apr 29, 2022 10-Q 2022-05-03
Q3 2021 51.4M +6.93M +15.6% Oct 29, 2021 10-Q 2021-11-10
Q2 2021 51M Jul 30, 2021 10-Q 2021-08-06
Q1 2021 45M Apr 30, 2021 10-Q 2021-05-06
Q3 2020 44.5M Oct 30, 2020 10-Q 2020-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.